Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Outsmarting smartphones: Technology reduces distracted driving among teens

  • Potential new treatment for multiple sclerosis

  • Bullying leads to depression and suicidal thoughts in teens

  • Stem-cell-based therapy promising for treatment of breast cancer metastases in the brain

  • Youths who survive self-poisoning continue to be at risk of suicide for years

  • We are family: Adult support reduces youths' risk of violence exposure

  • Parents sound off on mobile device use by children

  • Some children lose autism diagnosis but still struggle

  • Serving healthy foods with a smile may entice students to eat better

  • Mental disorders don't predict future violence, study suggests

  •